Teyi Pharmaceutical Group Co.,Ltd reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 583.05 million compared to CNY 525.47 million a year ago. Revenue was CNY 583.05 million compared to CNY 525.47 million a year ago.

Net income was CNY 97.77 million compared to CNY 102.87 million a year ago. Basic earnings per share from continuing operations was CNY 0.3143 compared to CNY 0.3643 a year ago. Diluted earnings per share from continuing operations was CNY 0.3143 compared to CNY 0.3643 a year ago.